Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices | News
Search Refinements

Drug Delivery Devices News

View news from other Medical Devices sectors:
76-90 of 561 results
MIT researchers develop new device to deliver chemotherapy drugs to pancreatic tumors
By MDBR Staff Writer
Researchers from the Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital (MGH) have developed a new implantable device, which delivers chemotherapy drugs directly to pancreatic tumors.
Specialty Devices > Drug Delivery Devices > News
SurModics begins feasibility study of SurVeil drug-coated balloon
By MDBR Staff Writer
Medical devices provider SurModics has recruited first patient in an early feasibility study of its SurVeil drug-coated balloon (DCB).
Specialty Devices > Drug Delivery Devices > News
Medtronic announces early data and completes enrollment in CE mark cohort in drug-filled stent trial
By MDBR Staff Writer
Medtronic announced new clinical data from one of the endpoints in the RevElution Trial for its novel, next-generation Drug-Filled Stent (DFS).
Specialty Devices > Drug Delivery Devices > News
Aethlon Medical discloses Hemopurifier clinical trial
By MDBR Staff Writer
Aethlon Medical reported that the recently appointed principal investigator of its FDA approved clinical study in Houston, Texas, has completed a six-treatment protocol of Hemopurifier therapy in an enrolled patient and has consented the enrollment of the next patient.
Specialty Devices > Drug Delivery Devices > News
Direct Flow Medical launches next generation TAVI delivery system
By MDBR Staff Writer
Direct Flow Medical, a medical device company developing and commercializing transcatheter heart valve therapy products to treat structural heart disease, today announced European commercial market launch of the DirecTrack™ Delivery System, a next generation delivery system for the Direct Flow Medical Transcatheter Aortic Valve System.
Specialty Devices > Drug Delivery Devices > News
BioTelemetry agrees to acquire VirtualScopics
By MDBR Staff Writer
Wireless medical technology firm BioTelemetry has agreed to acquire clinical trial imaging solutions provider VirtualScopics.
Specialty Devices > Drug Delivery Devices > News
Adherium establishes North American operations
By MDBR Staff Writer
Adherium, a global leader in digital health technologies addressing sub-optimal medication use in chronic disease, announced the establishment of a new entity in the North American market, Adherium North America, based in San Francisco.
Specialty Devices > Drug Delivery Devices > News
Micell completes enrollment in OCT study designed to evaluate superior performance of MiStent SES compared to Xience
By MDBR Staff Writer
Micell Technologies announced completion of enrollment in the MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) Optical Coherence Tomography (OCT) study.
Specialty Devices > Drug Delivery Devices > News
Stentys’ self-apposing stent gets CE mark approval to treat left main coronary artery disease
By MDBR Staff Writer
Medical technology firm Stentys has received CE mark approval for sirolimus-eluting self-apposing stent, Xposition S, to treat unprotected left main coronary artery disease.
Specialty Devices > Drug Delivery Devices > News
Luminex partners with Brazilian university to validate Zika virus detection panel
By MDBR Staff Writer
Biotechnology firm Luminex has formed a collaboration with the University of São Paulo, Brazil to validate a multi-analyte Zika virus assay, developed by GenArraytion.
Specialty Devices > Drug Delivery Devices > News
Boston Scientific’s Eluvia drug-eluting vascular stent system wins CE mark approval
By MDBR Staff Writer
Medical device manufacturer Boston Scientific has received CE mark approval in the European Union for its Eluvia drug-eluting vascular stent system.
Specialty Devices > Drug Delivery Devices > News
Delcath announces SPA agreement with FDA for new Phase 3 trial in hepatic dominant ocular melanoma
By MDBR Staff Writer
Delcath Systems, a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that the Company has reached a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for the design of Delcath's new Phase 3 clinical trial of Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) to treat patients with hepatic dominant ocular melanoma.
Specialty Devices > Drug Delivery Devices > News
Medtronic IN.PACT Admiral DEB Receives CE mark to treat AV access in patients with end-stage renal disease
By MDBR Staff Writer
Medtronic announced that the IN.PACT Admiral drug eluting balloon (DEB) (also known as the IN.PACT Admiral drug-coated balloon (DCB) in non-European markets) has received CE (Conformité Européene) Mark for arteriovenous (AV) access to help maintain hemodialysis access in patients with end-stage renal disease.
Specialty Devices > Drug Delivery Devices > News
Rani Therapeutics announces collaboration with MedImmune in metabolic disease field
By MDBR Staff Writer
Rani Therapeutics announced that it has entered into a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, to evaluate Rani's novel oral drug delivery platform.
Specialty Devices > Drug Delivery Devices > News
Medtronic announces new high-tech facility in Galway
By MDBR Staff Writer
Medtronic, a global leader in medical technology, services and solutions, today announced a new manufacturing facility in Galway, Ireland that will manufacture the market-leading IN.PACT® Admiral® drug-coated balloon (DCB) for the treatment of peripheral artery disease (PAD).
Specialty Devices > Drug Delivery Devices > News
76-90 of 561 results